Addiction Policy Forum

Public health and safety partners nationwide are warning about cychlorphine, an emerging synthetic opioid identified in the illicit drug supply across the United States. Cychlorphine belongs to a class of novel synthetic opioids known as “orphines.” It has been found on its own and in combination with fentanyl and other substances, including methamphetamine, cocaine, and counterfeit pills made to resemble prescription medications. The Office of National Drug Control Policy (ONDCP) at the...

Women with alcohol use disorder (AUD) may face unique barriers to care, including stigma, caregiving responsibilities, co-occurring mental health conditions, trauma exposure, and limited access to services designed to meet their needs. Understanding these factors is essential to improving equitable access to effective, person-centered treatment. This webinar will examine alcohol use and AUD among women in the United States, with a focus on the evidence base for treatment and clinical...

Alcohol use disorder (AUD) is among the most prevalent substance use disorders in the United States, affecting millions of people each year and contributing to significant health, social, and economic harms. Yet, despite the availability of effective behavioral interventions and medications, many individuals with AUD do not receive treatment. This webinar will provide an introduction to alcohol use and AUD in the United States, including epidemiologic trends, diagnostic criteria, and current...